Testing effectiveness (Phase 2)Study completedNCT00427557What this trial is testingCellular Therapy With Cord Blood CellsWho this might be right forMultiple MyelomaLeukemiaLymphoma M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT02797964What this trial is testingA Phase 1/2 Trial of SRA737 in Subjects With Advanced CancerWho this might be right forAdvanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL) Sierra Oncology LLC - a GSK company 107
Testing effectiveness (Phase 2)Study completedNCT00460109What this trial is testingRituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 24
Early research (Phase 1)Ended earlyNCT00005787What this trial is testingPeripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaNeutropenia Northwestern University 3
Not applicableLooking for participantsNCT07259304What this trial is testingSocial Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer SurvivorsWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+97 more University of Southern California 250
Testing effectiveness (Phase 2)Study completedNCT00005804What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT04553692What this trial is testingPhase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersWho this might be right forSolid TumorColorectal CancerNon Hodgkin Lymphoma+5 more IGM Biosciences, Inc. 272
Post-approval studies (Phase 4)Not Yet RecruitingNCT06761911What this trial is testingBV in the Treatment of Relapsed/refractory Hodgkin LymphomaWho this might be right forHodgkin Lymphoma (Category) Xiuhua Sun 100
Testing effectiveness (Phase 2)Study completedNCT00521014What this trial is testingGM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center 14
Early research (Phase 1)Active Not RecruitingNCT03713580What this trial is testingVenetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin LymphomaWho this might be right forNon-hodgkin Lymphoma Case Comprehensive Cancer Center 25
Early research (Phase 1)Looking for participantsNCT06544265What this trial is testingSynKIR-310 for Relapsed/Refractory B-NHLWho this might be right forB Cell LymphomaNHL, AdultMantle Cell Lymphoma+23 more Verismo Therapeutics 36
Testing effectiveness (Phase 2)Study completedNCT00726700What this trial is testingPegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin LymphomaWho this might be right forLymphoma Universität des Saarlandes 109
Testing effectiveness (Phase 2)Study completedNCT00062114What this trial is testingYttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 84
Large-scale testing (Phase 3)Study completedNCT00052936What this trial is testingCombination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma German High-Grade Non-Hodgkin's Lymphoma Study Group 1,506
Not applicableStudy completedNCT05972577What this trial is testingGeriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS StudyWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+9 more Ohio State University Comprehensive Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT01231412What this trial is testingGraft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell TransplantWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+16 more Fred Hutchinson Cancer Center 174
Early research (Phase 1)Study completedNCT01567709What this trial is testingAlisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT01008462What this trial is testingAutologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaWho this might be right forB-Cell Prolymphocytic LeukemiaHypodiploidyLoss of Chromosome 17p+18 more Fred Hutchinson Cancer Center 16
Testing effectiveness (Phase 2)Ended earlyNCT00474188What this trial is testingEvaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-cell Lymphoma Celgene Corporation 26
Testing effectiveness (Phase 2)Study completedNCT00496873What this trial is testingEvaluation of the Safety and Efficacy of Nipent, Cytoxan, and RituxanWho this might be right forLymphoma M.D. Anderson Cancer Center 100